Metformin may lower blood sugar via the gut, study suggests
Northwestern researchers report metformin acts in the gut to curb blood sugar, potentially expanding the drug's known mechanisms. The study also links a plant compound, berberine, to a similar gut-based effect.
Key takeaways
- Metformin may lower blood sugar by acting in the gut rather than exclusively in the liver.
- The study connects a plant compound, berberine, to a similar gut-based mechanism as metformin.
- Findings support considering gut-targeted approaches in future diabetes research.
What Happened
Researchers from Northwestern University explored how metformin lowers blood sugar and report that the drug exerts effects in the gut, not only in the liver as previously emphasized. The work, published in Nature Metabolism, involved human data and mouse experiments and points to the intestine absorbing glucose after meals influenced by metformin. The study also notes that a plant compound called berberine may operate through a comparable gut-related mechanism.
Why It Matters
The findings challenge long-standing assumptions about metformin’s primary site of action and highlight the gut as a major regulator of glucose balance. If the gut pathway is pivotal, it could influence how future diabetes therapies are developed and how existing treatments are used or combined with supplements.
Background
Metformin is one of the most prescribed diabetes medications in the United States, with more than 80 million prescriptions dispensed annually. Traditional thinking has emphasized its impact on the liver to reduce the amount of glucose entering the bloodstream. The Northwestern study revisits this narrative by focusing on intestinal processes and their relation to glucose handling after meals.
Key Facts
- Metformin is widely prescribed in the United States, with over 80 million annual prescriptions.
- The Northwestern study, published in Nature Metabolism, suggests metformin acts in the gut to help the intestine absorb glucose after meals.
- Evidence includes observations from human data and mouse experiments and mentions gut mitochondria as a relevant target.
- Patients taking metformin have clinical observations consistent with gut-mediated glucose lowering after eating.
- Berberine, a plant-derived compound sometimes labeled as Nature’s Ozempic, may operate via a similar gut-related mechanism according to the study’s discussion and cited sources.
- Experts warn against viewing berberine as a replacement for approved diabetes medications.
What Happens Next
The report indicates future drug and supplement research should consider targeting the gut to influence blood sugar levels, potentially guiding the development of new therapies or combination approaches.
Sources reviewed
Project Chintan independently synthesized and analyzed information cross-checked across the sources listed above.
Related stories
Kelly Ripa says over-brushing led to gum graft surgery
Toddlers Hospitalised with Kidney Failure After Petting Zoo Visit
Tirupattur Police Host Blood Donation Drive for Independence Day
